PDF(Pubmed)
Abstract：
UNASSIGNED: Comorbidities in patients with cancer can affect treatment, and should, therefore, be prioritized and managed.
UNASSIGNED: Our primary aim was to assess the prevalence of comorbidities among patients with cancer. The secondary objective was to identify the association of comorbidities with various sociodemographic and clinical variables.
UNASSIGNED: This was a cross-sectional study conducted between December 2019 and March 2020 among patients with cancer, seeking treatment at Malabar Cancer Center, in Kannur District of northern Kerala in South India. Semi-structured interviews were conducted, and comorbidities were assessed using the Charlson Comorbidity Index. The anthropometric measurements were recorded using a standardized instrument and protocol.
UNASSIGNED: We enrolled 242 patients in this study. There were 148 (61.2%) female patients; 106 (43.8%) were aged between 41 and 50 years. Cancers of the head-and-neck and breast accounted for the majority of cases (23.1% each, n = 56), followed by the digestive system (18.6%, n = 45) and female reproductive system (11.2%, n = 27). The most common primary cancers in the head-and-neck, digestive, and female reproductive systems were oral, colorectal, and cervical, respectively. The prevalence of comorbidities among patients with cancer was 70.2% (n = 170). Common comorbidities were hypertension (n = 82 ; 33.9%), arthritis (n = 57; 23.6%), and diabetes (n = 53; 21.6%). After controlling for potential confounders, the factors noted to be independently associated with the presence of comorbidities were advanced age, family history of comorbidity, normal weight or underweight, and cancer treatment for more than 6 months\' duration.
UNASSIGNED: The high prevalence of comorbidities among patients with cancer suggests the need for an integrated system of care and management as the comorbidities affect the overall management of cancer treatment and care.
UNASSIGNED: Our primary aim was to assess the prevalence of comorbidities among patients with cancer. The secondary objective was to identify the association of comorbidities with various sociodemographic and clinical variables.
UNASSIGNED: This was a cross-sectional study conducted between December 2019 and March 2020 among patients with cancer, seeking treatment at Malabar Cancer Center, in Kannur District of northern Kerala in South India. Semi-structured interviews were conducted, and comorbidities were assessed using the Charlson Comorbidity Index. The anthropometric measurements were recorded using a standardized instrument and protocol.
UNASSIGNED: We enrolled 242 patients in this study. There were 148 (61.2%) female patients; 106 (43.8%) were aged between 41 and 50 years. Cancers of the head-and-neck and breast accounted for the majority of cases (23.1% each, n = 56), followed by the digestive system (18.6%, n = 45) and female reproductive system (11.2%, n = 27). The most common primary cancers in the head-and-neck, digestive, and female reproductive systems were oral, colorectal, and cervical, respectively. The prevalence of comorbidities among patients with cancer was 70.2% (n = 170). Common comorbidities were hypertension (n = 82 ; 33.9%), arthritis (n = 57; 23.6%), and diabetes (n = 53; 21.6%). After controlling for potential confounders, the factors noted to be independently associated with the presence of comorbidities were advanced age, family history of comorbidity, normal weight or underweight, and cancer treatment for more than 6 months\' duration.
UNASSIGNED: The high prevalence of comorbidities among patients with cancer suggests the need for an integrated system of care and management as the comorbidities affect the overall management of cancer treatment and care.
摘要：
■癌症患者的合并症会影响治疗，并且应该，因此,优先考虑和管理。
■我们的主要目的是评估癌症患者合并症的患病率。次要目标是确定合并症与各种社会人口统计学和临床变量的关联。
■这是一项在2019年12月至2020年3月期间对癌症患者进行的横断面研究。在马拉巴尔癌症中心寻求治疗，位于印度南部喀拉拉邦北部的坎努尔区。进行了半结构化访谈，和合并症使用Charlson合并症指数进行评估。使用标准化仪器和方案记录人体测量测量。
■我们在这项研究中招募了242名患者。有148名（61.2％）女性患者；106名（43.8％）年龄在41至50岁之间。头颈部和乳腺癌占大多数病例（各占23.1%，n=56),其次是消化系统(18.6%，n=45）和女性生殖系统（11.2%，n=27）。头颈部最常见的原发癌，消化性,女性生殖系统是口腔的，结直肠,和子宫颈，分别。癌症患者合并症的患病率为70.2%(n=170)。常见的合并症是高血压（n=82;33.9%），关节炎（n=57;23.6％），和糖尿病（n=53；21.6％）。在控制了潜在的混杂因素后，注意到与合并症的存在独立相关的因素是高龄，合并症家族史，正常体重或体重不足，和癌症治疗超过6个月的持续时间。
癌症患者合并症的高患病率表明需要一个综合的护理和管理系统，因为合并症会影响癌症治疗和护理的整体管理。
■我们的主要目的是评估癌症患者合并症的患病率。次要目标是确定合并症与各种社会人口统计学和临床变量的关联。
■这是一项在2019年12月至2020年3月期间对癌症患者进行的横断面研究。在马拉巴尔癌症中心寻求治疗，位于印度南部喀拉拉邦北部的坎努尔区。进行了半结构化访谈，和合并症使用Charlson合并症指数进行评估。使用标准化仪器和方案记录人体测量测量。
■我们在这项研究中招募了242名患者。有148名（61.2％）女性患者；106名（43.8％）年龄在41至50岁之间。头颈部和乳腺癌占大多数病例（各占23.1%，n=56),其次是消化系统(18.6%，n=45）和女性生殖系统（11.2%，n=27）。头颈部最常见的原发癌，消化性,女性生殖系统是口腔的，结直肠,和子宫颈，分别。癌症患者合并症的患病率为70.2%(n=170)。常见的合并症是高血压（n=82;33.9%），关节炎（n=57;23.6％），和糖尿病（n=53；21.6％）。在控制了潜在的混杂因素后，注意到与合并症的存在独立相关的因素是高龄，合并症家族史，正常体重或体重不足，和癌症治疗超过6个月的持续时间。
癌症患者合并症的高患病率表明需要一个综合的护理和管理系统，因为合并症会影响癌症治疗和护理的整体管理。
